Strides Pharma Science Limited — Dividend/Bonus, 18-05-2026: Dividend

Strides Pharma Science's Board recently met and approved the financial results for the quarter and full year ended March 31, 2026. The Board also proposed a final dividend of Rs 5 per equity share (50% on Rs 10 face value) for the financial year. This dividend, amounting to approximately Rs 46.1 crore in cash outflow, is subject to shareholder approval at the upcoming Annual General Meeting. The record date will be set in due course, with payment expected within 30 days of shareholder consent.